Bolzoni et al. demonstrated that bone marrow CD14+CD16+ monocytes from patients with multiple myeloma tended to differentiate into osteoclasts more remarkably than CD14+CD16− monocytes [9]. This evidence concerns the gene CD14 and plasma cell myeloma.